Linda van Bijsterveldt
I am looking into the role of a particular miRNA in regulating breast cancer pathogenesis. We have shown that over-expression of this miRNA alters the cell cycle profile of triple-negative breast cancer cell lines and are looking to target this with checkpoint kinase inhibitors, based on a concept called synthetic lethality.
I graduated from Leiden University (2016) with a BSc in Bio-Pharmaceutical Sciences. I then obtained a MSc by Research in Oncology (2017) from the University of Oxford (Chromosome Integrity Group), where I identified suppressors of the synthetic lethality resulting from loss of SETD2 and WEE1.